Prostate Cancer
FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
August 23, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
August 23, 2023
Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?
August 23, 2023
Assessment of bladder filling during prostate cancer radiation therapy with ultrasound and cone-beam CT.
August 22, 2023
Proton Therapy for the Management of Localized Prostate Cancer: Long-Term Clinical Outcomes at a Comprehensive Cancer Center.
August 22, 2023
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial
August 21, 2023
The impact of race on survival in metastatic prostate cancer: a systematic literature review.
August 21, 2023
Prostagram MRI in a Screening Population: PI-RADS or Likert?
August 21, 2023